$AUPH Aurinia Pharmaceuticals Inc. Insider Trading
Get free email notifications about insider trading in Aurinia Pharmaceuticals Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Aurinia Pharmaceuticals Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Aurinia Pharmaceuticals Inc. for free.
CIK Number: 0001600620
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: AUPH
Company Address: #1203-4464 MARKHAM STREET VICTORIA BC V8Z 7X8
Phone number: 250-708-4272
Aurinia Pharmaceuticals Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 23 2021 | AUPH | Aurinia Pharmaceut ... | Martin Michael Robert | Chief Business Offi ... | Sell | S | 13.76 | 5,000 | 68,800 | 216,861 | 221.9 K to 216.9 K (-2.25 %) |
Jun 16 2021 | AUPH | Aurinia Pharmaceut ... | Billen Daniel | Director | Option Exercise | A | 12.86 | 31,347 | 403,122 | 31,347 | |
May 13 2021 | AUPH | Aurinia Pharmaceut ... | MacKay-Dunn R. Hector | Director | Buy | P | 11.28 | 1,600 | 18,040 | 6,000 | 4.4 K to 6 K (+36.36 %) |
May 13 2021 | AUPH | Aurinia Pharmaceut ... | MacKay-Dunn R. Hector | Director | Buy | P | 11.26 | 1,400 | 15,764 | 4,400 | 3 K to 4.4 K (+46.67 %) |
May 13 2021 | AUPH | Aurinia Pharmaceut ... | MacKay-Dunn R. Hector | Director | Buy | P | 11.14 | 1,000 | 11,140 | 3,000 | 2 K to 3 K (+50.00 %) |
May 13 2021 | AUPH | Aurinia Pharmaceut ... | MacKay-Dunn R. Hector | Director | Buy | P | 11.17 | 500 | 5,585 | 2,000 | 1.5 K to 2 K (+33.33 %) |
May 12 2021 | AUPH | Aurinia Pharmaceut ... | Donley Matthew Maxwell | Ex VP, Intern'l Ope ... | Buy | P | 10.07 | 9,900 | 99,739 | 9,900 | 0 to 9.9 K |
May 12 2021 | AUPH | Aurinia Pharmaceut ... | Greenleaf Peter | Chief Executive Off ... | Buy | P | 11.11 | 2,992 | 33,241 | 13,453 | 10.5 K to 13.5 K (+28.60 %) |
May 12 2021 | AUPH | Aurinia Pharmaceut ... | Greenleaf Peter | Chief Executive Off ... | Buy | P | 10.15 | 2,133 | 21,650 | 10,461 | 8.3 K to 10.5 K (+25.61 %) |
May 12 2021 | AUPH | Aurinia Pharmaceut ... | Leversage Jill | Director | Buy | P | 10.96 | 2,500 | 27,389 | 3,700 | 1.2 K to 3.7 K (+208.33 %) |
May 11 2021 | AUPH | Aurinia Pharmaceut ... | Huizinga Robert Bindert | Ex Vice President o ... | Option Exercise | M | 3.02 | 40,000 | 120,800 | 0 | |
May 11 2021 | AUPH | Aurinia Pharmaceut ... | Huizinga Robert Bindert | Ex Vice President o ... | Buy | M | 3.02 | 40,000 | 120,800 | 143,592 | 103.6 K to 143.6 K (+38.61 %) |
May 11 2021 | AUPH | Aurinia Pharmaceut ... | Miller Joseph M | Chief Financial Off ... | Buy | P | 9.74 | 1,000 | 9,740 | 1,000 | 0 to 1,000 |
May 11 2021 | AUPH | Aurinia Pharmaceut ... | Miller Joseph M | Chief Financial Off ... | Buy | P | 9.74 | 1,000 | 9,740 | 1,000 | 0 to 1,000 |
Mar 15 2021 | AUPH | Aurinia Pharmaceut ... | Solomons Neil | Chief Medical Offic ... | Option Exercise | M | 3.02 | 40,000 | 120,800 | 0 |